Literature DB >> 16120060

Changes in the usage of antihypertensive drugs: implications and prospects.

Mike Schachter.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 16120060      PMCID: PMC1884772          DOI: 10.1111/j.1365-2125.2005.02421.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  24 in total

Review 1.  Calcium channel blockers: an update.

Authors:  Mark J Eisenberg; Anya Brox; Alain N Bestawros
Journal:  Am J Med       Date:  2004-01-01       Impact factor: 4.965

2.  Rise of blood pressure with age. New evidence of population differences.

Authors:  B L Rodriguez; D R Labarthe; B Huang; J Lopez-Gomez
Journal:  Hypertension       Date:  1994-12       Impact factor: 10.190

3.  Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren.

Authors:  Alice Stanton; Chris Jensen; Juerg Nussberger; Eoin O'Brien
Journal:  Hypertension       Date:  2003-11-03       Impact factor: 10.190

Review 4.  Treatment of hypertension in the elderly.

Authors:  A F Lever; L E Ramsay
Journal:  J Hypertens       Date:  1995-06       Impact factor: 4.844

Review 5.  Trends in pharmacogenomics of drugs acting on hypertension.

Authors:  Roberto Trotta; Maria Benedetta Donati; Licia Iacoviello
Journal:  Pharmacol Res       Date:  2004-04       Impact factor: 7.658

6.  Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.

Authors:  Tord Ekbom; Erland Linjer; Thomas Hedner; Jan Lanke; Ulf De Faire; P-O Wester; Björn Dahlöf; Bengt Scherstén
Journal:  Blood Press       Date:  2004       Impact factor: 2.835

Review 7.  Epidemiological, pathophysiological and clinical significance of systolic, diastolic and pulse pressure.

Authors:  D G Beevers
Journal:  J Hum Hypertens       Date:  2004-08       Impact factor: 3.012

8.  British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary.

Authors:  Bryan Williams; Neil R Poulter; Morris J Brown; Mark Davis; Gordon T McInnes; John F Potter; Peter S Sever; Simon McG Thom
Journal:  BMJ       Date:  2004-03-13

9.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

10.  Hypertension management and control among English adults aged 65 years and older in 2000 and 2001.

Authors:  Paola Primatesta; Neil R Poulter
Journal:  J Hypertens       Date:  2004-06       Impact factor: 4.844

View more
  1 in total

1.  Chronic p38 mitogen-activated protein kinase inhibition improves vascular function and remodeling in angiotensin II-dependent hypertension.

Authors:  S A Potthoff; S Stamer; K Grave; E Königshausen; S H Sivritas; M Thieme; Y Mori; M Woznowski; L C Rump; J Stegbauer
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-07-12       Impact factor: 1.636

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.